EMPHARM-NET
70 posts
EMPHARM-NET
@EMPHARM_NET
Emergency Medicine PHARMacotherapy research NETwork 🚨 Pushing the EM PharmD profession forward through high quality, collaborative research 📄
Katılım Şubat 2021
835 Takip Edilen1.5K Takipçiler
📢Check out our new publication on forming & maintaining a research network: Emergency Medicine PHARMacotherapy research NETwork (EMPHARM-NET), established to unify investigators, foster mentorship, & advance high-quality EM research authors.elsevier.com/a/1mlSz2dHVQKN…
English
📣 Calling all EM clinicians: please take our IRB-approved anonymous survey examining awareness & experience with anti-amyloid therapies
Survey link: redcap.link/anti-amyloid_t…
We aim to reach a broad EM audience to characterize awareness of AATs & compile innovative strategies
English
EMPHARM-NET retweetledi
@bfaine1 & I penned an editorial called Pharmacists on the Front Lines: Advances in Emergency Medicine Pharmacy Practice on the history and advancement of EM pharmacy culminating in this EM themed issue🚨
academic.oup.com/ajhp/article/8…
English
EMPHARM-NET retweetledi
Excited to share the Emergency Medicine themed issue of @ASHPOfficial @AJHPOfficial that I guested edited w/ @bfaine1.
20 ( ‼️ ) papers & >50 EM pharmacists - this is a testament to how talented and diverse our EM pharmacy community is!
Read here 👉academic.oup.com/ajhp/issue/82/…
English
EMPHARM-NET retweetledi
💡 Need one more reason to love your friendly EM pharmacist? Check out this @EMPHARM_NET SR/MA:
⏰ EMP presence was associated with reduced mean DTN time by 14.6 minutes (95 % CI -18.1, −11.1 min)
Time for @American_Stroke @American_Heart to take notice?
Kevin Mercer, PharmD, MPH@ohsnapimginger
Just published in #AJEM! 📄 #PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑 📉 Faster treatment 🤝 More interprofessionalism 🏥 Justification for expanding #EMPharmD services doi.org/10.1016/j.ajem…
English
Check out our new SR/MA on the benefits of an EM pharmacist on thrombolytic DTN time in acute ischemic stroke 🧠
Kevin Mercer, PharmD, MPH@ohsnapimginger
Just published in #AJEM! 📄 #PhAST1 is the first systematic review & meta-analysis quantifying the impact of #EMPharmD on stroke #doortoneedle times 🧠🚑 📉 Faster treatment 🤝 More interprofessionalism 🏥 Justification for expanding #EMPharmD services doi.org/10.1016/j.ajem…
English
🔥 New study HBV s/p sexual assault:
🏥 1010 patients, 10 @EMPHARM_NET EDs
💉 62.7 % with no/unknown vaccine history - only 5.8% received HBV vaccine
🧪 HBV serology testing 63.6%
🦠 8 patients received HBIG
🚨 Room for improvement in HBV care
Free link: sciencedirect.com/science/articl…
English
🔥 Off the Press: Risk factors for enterococcal UTI in ED patients (n=1836, 5% Enterococcus)
🧪 Combination of positive leukocyte esterase (LE+) and negative nitrite (NI−) significantly associated w/ Enterococcus UTI (aOR 7.1, 95 % CI 3.73–13.5)
sciencedirect.com/science/articl…
English
EMPHARM-NET retweetledi
📣Have you heard of antiamyloid therapies for AD? They cause ADEs called ARIAs that are non-specific, typically require MRI & can mimic stroke
⛔ Concomitant thrombolytics/anticoagulants are contraindicated
Learn more in our JAMA IM Clinical Insight👉 jamanetwork.com/journals/jamai…
English
EMPHARM-NET retweetledi
So excited to announce that @SAEM_AEMP is officially an @SAEMonline Academy! Thanks so everyone who worked so hard to get us to this point & continue to promote our mission of advancing EM pharmacy practice! So grateful to work with all of you! @LRayRx @EmergPharm
English
EMPHARM-NET retweetledi
🎉 Big news from #SAEM25 -- AEMP is officially transitioning to an academy within SAEM!!
🥳 We are so excited for the opportunities this will offer us!
🥂 Thankful for all our members & the group of EM pharmacist leaders who made this possible!!
#AEMPlify #AEMP25 @SAEMonline
English
Hot off the press: 🔥
New EMPHARM-NET study on desmopressin administration in antiplatelet-related ICH. Link here 👇
Megan Rech, PharmD, MS@MeganARech
🔥New @EMPHARM_NET DONT EXPAND Study: 💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140) 😷Desmo patients had higher baseline ICH volumes 🧠No difference in good or excellent hemostatic efficacy assessed via hematoma volume measures sciencedirect.com/science/articl…
English
📣Check out our latest publication📣
The 2024 EM Pharmacotherapy literature review is here. Check out the most impactful studies of the last year 👇
Ryan Feldman (empoisonpharmd.bsky.social)@EMPoisonPharmD
🚨 Just published in AJEM from @EMPHARM_NET: CuratED: The 2024 Emergency Medicine Drug Lit Review 🔥 11 RCTs 📜 10 guidelines 🔍 7 meta-analyses 💊 DAPT & stroke, steroids & CAP, TXA & ICH, Andexxa & more Stay EM Pharm sharp👇 🔗 doi.org/10.1016/j.ajem… #FOAMed #MedED
English
Our COPY-ED study was highlighted in NEJM Journal Watch: jwatch.org/na58569/2025/0…
@bfaine1 @ThePeoplesRuben @giles_slocum @DEZ_EM_Pharm @gavin_howington @AM_EM_PharmD @annezepeski @MeganARech
English
🔥Hot off the press: @EMPHARM_NET COPY-ED Study:
💊 Oral cephalosporins (n=647) vs IDSA guideline concordant FQ or TMP-SMX (n=204) for pyelonephritis in patients discharged from the ED
🙅♀️No difference in 14 d treatment failure
@jlkoehl @bfaine1
sciencedirect.com/science/articl…
English
EMPHARM-NET retweetledi
🚨Should sugammadex be used to reverse the effects of rocuronium in the ED? 🚨
Check out our new @AnnalsofEM Clinical Controversy to learn why you should use it:
sciencedirect.com/science/articl…
@MGottliebMD
🥊Opposing side coming soon from @EmergPharm & @AM_EM_PharmD
English
EMPHARM-NET retweetledi
🥊 Sugammadex should NOT be routinely used to reverse to reverse rocuronium for patients in the ED with @AM_EM_PharmD
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
Shout out to @MeganARech and @MGottliebMD for their take on the pro side!
Megan Rech, PharmD, MS@MeganARech
🚨Should sugammadex be used to reverse the effects of rocuronium in the ED? 🚨 Check out our new @AnnalsofEM Clinical Controversy to learn why you should use it: sciencedirect.com/science/articl… @MGottliebMD 🥊Opposing side coming soon from @EmergPharm & @AM_EM_PharmD
English